CPHI vs SNPS · rev $4.1M vs P/E 63, rev $7.05B
China Pharma Holdings Inc (CPHI) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
CPHI currently screens at market cap $29.0M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the CPHI and SNPS stock pages for the full models.
Not investment advice.